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Abstract Separate murine knockout (KO) of either c- or N-
myc genes in neural stem and precursor cells (NSC) driven
by nestin-cre causes microcephaly. The cerebellum is
particularly affected in the N-myc KO, leading to a strong
reduction in cerebellar granule neural progenitors (CGNP)
and mature granule neurons. In humans, mutation of N-myc
also causes microcephaly in Feingold Syndrome. We
created a double KO (DKO) of c- and N-myc using
nestin-cre, which strongly impairs brain growth, particu-
larly that of the cerebellum. Granule neurons were almost
absent from the Myc DKO cerebellum, and other cell
types were relatively overrepresented, including astroglia,
oligodendrocytes, and Purkinje neurons. These findings
are indicative of a profound disruption of cell fate of
cerebellar stem and precursors. DKO Purkinje neurons
were strikingly lacking in normal arborization. Inhibitory
neurons were ectopic and exhibited very abnormal
GAD67 staining patterns. Also consistent with altered cell
fate, the adult DKO cerebellum still retained a residual
external germinal layer (EGL). CGNP in the DKO EGL
were almost uniformly NeuN and p27KIP1 positive as
well as negative for Math1 and BrdU at the peak of
normal cerebellar proliferation at P6. The presence of
some mitotic CGNP in the absence of S phase cells
suggests a possible arrest in M phase. CGNP and NSC
metabolism also was affected by loss of Myc as DKO
cells exhibited weak nucleolin staining. Together these
findings indicate that c- and N-Myc direct cerebellar
development by maintaining CGNP and NSC populations
through inhibiting differentiation as well as directing rapid
cell cycling and active cellular metabolism.
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Introduction
Myc is most well known for its role in tumorigenesis when
overexpressed including medulloblastomagenesis [1–6], but
at physiological levels myc genes are important regulators
of many aspects of normal cellular biological behavior
including cellular metabolism and cell cycling (Reviewed
in [7]). Myc genes encode atypical members of the basic-
helix-loop-helix zipper transcription factor superfamily,
which can activate and repress the transcription of specific
genes. In addition in some cells including cerebellar granule
neural progenitors (CGNP), they can act more globally on
chromatin to maintain euchromatic domains associated with
specific histone modifications such as acetylation of lysine 9
and methylation of lysine 4 of histone H3, as well as others
including modifications of histone H4 [8–13].
While the vast majority of Myc studies have been
conducted in tumor cells, there is growing evidence of key
roles for myc genes at endogenous levels in both somatic
and embryonic stem cells. Constitutive knockout (KO) of c-
or N-myc causes embryonic lethality around midgestation
[14, 15]. Conditional disruption of N-myc in neural stem
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growth, particularly that of the cerebellum, while a similar
KO of c-myc moderately impairs growth [16, 17]. Disrup-
tion of either c- or N-myc or both in hematopoietic stem
cells (HSC) also alters their normal biological functions,
affecting survival and self-renewal [18, 19]. These studies
support the hypothesis that every normal cell has a
requirement for some minimum level of myc. myc genes
also are involved in the production of induced pluripotent
stem (iPS) cells (reviewed in [20]) [21–25]. While
exogenous Myc is not formally required for the process
[26, 27], it dramatically enhances the efficiency and in its
absence its function is likely supplanted by endogenous
myc. Data suggests that during iPS cell formation, Myc
represses differentiation-associated genes [28] and may not
have a key role in directly maintaining expression of
pluripotency factors. However, in neuroblastoma and other
tumors, some pluripotency genes such as lif, lin28b, Klf2,
and Klf4 are N-Myc targets for activation, while a subset of
these genes is also regulated in NSC by N-Myc [29].
Perhaps because ofthe importance of myc genes in normal
cellular biology and their ability to cause cancer when in
excess, cells have evolved systems to maintain normal total
cumulative myc RNA and Myc protein levels. These include
cross-regulation, redundancy and compensation between the
three main myc genes—c-, N-, and L-myc—as well as Myc-
trigged apoptosis when in excess. Myc protein stability is
also tightly controlled (reviewed in [30]). While desirable for
the cell and organism, this interconnectedness has made it
more difficult for the biologist to discern the specific roles of
individual myc genes through methods such as KO studies.
For example, despite fairly ubiquitous expression in the
developing brain and some other regions of the embryo, L-
myc constitutive KO was reported to have no phenotype at
all [31]. One theory is that this lack of apparent phenotype
was due to the continued presence of N-myc and perhaps c-
myc, which could fulfill the roles of L-myc.I nc o n t r a s t ,
constitutive KO of either c- or N-myc resulted in midgesta-
tional lethality [14, 15, 32], suggesting their overall
embryonic functions are to some critical degree unique or
their loss cannot be compensated for. Conditional double
knockout (DKO) of c- and N-myc in hematopoietic stem
cells yields a far more severe phenotype than disruption of
either gene alone, suggesting additive or redundant roles
[19]. A large degree of redundancy is also supported by the
knocking of N-myc into the c-myc locus largely rescuing the
loss of c-myc [33]. The prevailing theory is that what is most
critical is the total level of all myc gene expression in each
cell.
During neurogenesis, N-myc plays a particularly impor-
tant role in NSC to direct overall brain and particularly
cerebellar growth [16, 34], consistent with its fairly
widespread expression pattern in the brain throughout
embryogenesis including very high levels in the developing
cerebellum. L-myc is also fairly widely expressed, particu-
larly in the early midbrain, which suggests it may function in
the brain despite no reported KO phenotype. Although c-myc
expression has been less clearly defined, it appears to be
more restricted than that of L- and N-myc. In vitro
overexpression and c-myc KO studies in rat neurospheres
support a crucial role for myc genes overall in NSC function
and suggested functional ties to p53/Arf [35], but the
relevance for in vivo neurogenesis remained unclear. While
no nestin-cre L-myc conditional knockout has been reported,
single nestin-cre-driven knockout of c-myc in NSC impairs
brain growth, but far less severely than loss of N-myc and
with no cerebellar specific phenotype [16, 34]. The
molecular basis of the c- and N-myc nestin-cre-driven brain
phenotypes is not completely clear, but in the N-myc
knockout changes in cyclin D2 and cyclin-dependent kinase
inhibitors such as p18INK4C and p27KIP1 were evident
suggesting cell cycle regulation plays an important role [16,
36], including in the cerebellum. However, no unbiased
global analysis of gene expression has been conducted for
myc genes using a loss of function model in the developing
brain or specifically in the cerebellum. Upstream of N-myc
are several potential signaling pathways including Shh in the
cerebellum and in CGNPs [17, 37], while N-myc also
appears to be a critical part of a newly defined pathway
DLL3 and Notch signaling in which N-Myc protein is
targeted by the Huwe1 ubiquitin ligase [38, 39].
To address the endogenous functions of c- and N-myc in
cerebellar development, we created a nervous system
specific double c- and N-myc KO mouse by crossing
doubly homozygously myc floxed mice with nestin-cre,
which is expressed specifically in NSC and at very high
levels in CGNP and in NSC of the cerebellum neuro-
epithelium. The myc DKO mice have a nervous system
phenotype much more severe than either single myc KO
alone, which is ultimately lethal. In terms of mechanisms,
we found evidence that Myc regulates transcriptional
programs including that of metabolic genes essential for
normal stem and precursor fate during cerebellar genesis.
Methods and Methods
Animals
Breeding pairs of nestin-Cre− N-myc
(FL/FL) c-myc
(FL/FL) and
nestin-Cre+ N-myc
(FL/WT) c-myc
(FL/FL) [10]w e r es e tu pt o
generate the four genotypes Nestin-Cre− N-myc
(FL/FL) c-
myc
(FL/FL), Nestin-Cre− N-myc
(FL/WT) c-myc
(FL/FL),N e s t i n -
Cre+ N-myc
(FL/FL) c-myc
(FL/FL), and nestin-Cre+ N-myc
(FL/WT)
c-myc
(FL/FL). Genotypes of animals were determined via
polymerase chain reaction (PCR) using primer sets for Cre,
538 Cerebellum (2010) 9:537–547N-myc and c-myc. Primer sequences were as follow: Cre1:
GCC TGC ATTACC GGT CGATGC AAC GA; Cre2: GTG
GCA GAT GGC GCG GCA ACA ACC ATT; N-myc1: GTC
GCG CTA GTA AGA GCT GAG ATC; N-myc2: GGC ACA
CAC CTA TAA TCC CAG CTA; N-myc3: CAC AGC TCT
GGA AGG TGG GAG AAA GTT GAG CGT CTC C; c-
myc1: GCC CCT GAATTG CTA GGA AGA CTG; c-myc2:
CCG ACC GGG TCC GAG TCC CTA TT. Cre1 and 2
primer set amplified a 700 bp band from Cre insertion. The
flox-specific band for N-myc1, 2, and 3 primers is 260 bp,
the wild-type band is 217 bp, and the deletion band is
350 bp. The flox-specific band for c-myc1a n d2p r i m e rs e t
is 500 bp, and the wild-type band is 400 bp. A separate
primer set to detect c-myc deletion, c-mycDS: TCG CGC
CCC TGA ATT GCTAGG AA, and c-mycDA: TGC CCA
GAT AGG GAG CTG TGA TAC TT, were used and
amplifies a band at ~750 bp.
Immunohisto- and Cytochemistry
All E12.5 embryos were immersion-fixed overnight in
fresh, buffered 4% paraformaldehyde, paraffin embedded
and cut (12 μm) sagittally. Pregnant female were
anesthetized with 150 mg/kg ketamine and 16 mg/kg
xylazine, then E17.5 embryos were removed individual-
ly and perfused with buffered 4% paraformaldehyde.
Brains were removed and fixed overnight in fresh,
buffered 4% paraformaldehyde, then cryopreserved and
cut (12 μm) sagittally. For immunostaining, E12.5
embryo sections were deparaffinized then rehydrated
and 30 mM sodium citrate treated for 10 min at 95°C,
while E17.5 frozen brain sections were post-fixed in
−20°C Acetone for 10 min followed by three 5 min
PBS wash. All sections were blocked in 10% normal
goat serum in PBS for 1 h at room temperature then
incubated in primary antibody overnight at 4°C. Anti-
bodies used include anti-BrdU (Chemicon MAB3424,
1:150), anti-PhosphoH3 (Upstate 06-570, 1:200), and
anti-TubulinßIII (TUJ; Covance PRB-435P, 1:150). The
next day, sections were washed in PBS three times
10 min each, and then incubated in secondary antibody
for 2 h at room temperature. Alexa Fluor Goat α Rabbit
IgG λ488 (Invitrogen A11008) and Alexa Fluor Goat α
Mouse IgG λ546 (Invitrogen A 11003) were used at
1:1,000 dilution. Sections were washed again in PBS
three times 10 min each, and then mounted in
Vectashield mounting medium with DAPI (VECTOR H-
1200). Anti-BrdU staining was conducted on embryos
from pregnant females who were IP injected with BrdU
(Sigma B5002, 150 μg/g) following a 2–4hB r d U
incorporation period. TUNEL staining was performed
using the DeadEnd Fluorometric TUNEL System Kit
(Promega G3250) as directed.
Microarray and Quantitative Real-Time PCR
Cortex, midbrain and cerebellum were dissected from
brains of freshly sacrificed E17.5 embryos. Total RNA
was isolated from these brain areas using RNeasy Mini Kit
(Qiagen 74134) with DNaseI digestion (Invitrogen 18068-
015) performed post-RNA extraction. Quality of RNA was
checked and cRNA was produced by UC Davis Gene
Expression Analysis facility for hybridization to Sentrix
Mouse Ref-8 Expression microarray. qPCR was performed
on total RNA from the same batch sent off for array.
Samples were processed using Express SYBR Green
qPCR Supermix (Invitrogen A10314) according to
manufacture protocol. All qPCR data were generated
using ß-Actin as reference (house-keeping) gene. This
gene was chosen based on microarray results, which
showed no significant expression variation between
control and double knockout brains. Primer efficiency
was tested by generating standard curves for all primers
against all brain areas. Cycling was conducted as follows:
pre-incubation at 95°C for 5 min, 45 cycles of amplifica-
tion at 95°C for 10 s, 60°C for 20 s, and 72°C for 30 s,
followed by one cycle of melting curve at 95°C for 5 s,
65°C for 1 min, and 97°C continuous.
Results
Double Knockout of c- and N-myc in NSC Severely
Disrupts Brain and Cerebellar Growth, Resulting
in Lethality as Early as E17.5
Previous separate single conditional targeted disruption
of either c- or N-myc in NSC using nestin-cre caused
varying degrees of impaired brain growth manifesting as
microcephaly, however even in the case of N-myc,w h i c h
h a da> 4 0 %r e d u c t i o ni nb r a i ng r o w t h ,t h e r ew a sn o
lethality apparent [16]. In those studies, an underrepresen-
tation of N-myc flox/flox nestin-cre (NSC specific N-myc
knockout) mice was present in breedings of N-myc flox/
flox X N-myc flox/WT nestin-cre mice, but equally
underrepresented were N-myc flox/WT cre-negative
(healthy, non-phenotypic) offspring, indicating that there
was likely a genetic linkage between the N-myc WT allele
and the nestin-cre transgene [16], which caused these non-
Mendelian, yet consistently observed ratios. Consistent
with the theory of linkage, both N-myc and the nestin-cre
transgene have been mapped on mouse chromosome 12,
but quite some distance apart (Roussel M. and Zindy, F.,
unpublished observation).
In our current DKO studies, when we did an equivalent
breeding (bred N-myc flox/flox; c-myc flox/flox (doubly
homozygously floxed) mice with N-myc flox/WT; c-myc
Cerebellum (2010) 9:537–547 539flox/flox nestin-cre mice) we also observed evidence of this
linkage, with a parallel underrepresentation of N-myc flox/
WT; c-myc flox/flox cre-negative (healthy controls) and
doubly homozygously floxed nestin-cre (DKO) mice. This
was evident at some early embryonic stages examined
(Fig. 1a), where only 1/6 mice (instead of one fourth) were
N-myc flox/WT; c-myc flox/flox, and only 1/6 were N-myc
flox/flox; c-myc flox/flox nestin-cre+. However, by age
E17.5 doubly homozygously floxed nestin-cre embryos
(DKO) began to be underrepresented even compared to N-
myc flox/WT; c-myc flox/flox control embryos, with which
they were earlier balanced in numbers. This specific
underrepresentation was by ratios of approximately 2-fold
or more indicating lethality, which became progressively
more severe with age. By P21, there was a 2.5-fold
underrepresentation of DKO compared with N-myc flox/
WT; c-myc flox/flox control embryos (Fig. 1). By 4–
6 weeks of age, only extraordinarily rare DKO animals
survived (<5%), while N-myc flox/WT; c-myc flox/flox cre-
negative mice were surviving normally and appeared
healthy. After birth, surviving DKO animals were outwardly
small and had severe ataxia.
Brain growth was severely impaired in the DKO mice,
likely explaining their lethality. The few DKO animals
surviving to maturity had a 60% reduction in total brain
growth and a near complete absence of cerebellar growth
(Fig. 1b). Mice heterozygous for c-myc, but homozygously
null for N-myc were not produced in the breeding in
Fig. 1a, however they exhibited a phenotype almost as
severe with a 53% reduction in brain growth. Surprisingly,
mice heterozygous for N-myc, but homozygously null for c-
myc had a brain growth phenotype only slightly more
severe than homozygously null c-myc animals with WT N-
myc (24% vs 18% reductions in brain growth), indicating
that knocking out one allele of N-myc has little effect even
in the context of absent c-myc (Fig. 1b).
Loss of c- and N-myc Strongly Impairs Early Cerebellar
Development
At E17.5, cerebellar growth was strongly impaired in the
DKO (Fig. 2a) as was overall brain growth (not shown). By
P6, the cerebellar phenotype became more severe (Fig. 2b).
DKO cerebellar size at P6 was only a fewfold increased
compared with the DKO at E17.5 indicating minimal
cerebellar growth and development occurs in the DKO
during that approximately 8 day period of time. The
morphology of the E17.5 and P6 DKO cerebella were also
quitesimilar.WhiletheDKOcerebelladidgrowfromE17.5-
P6 moderately, it is notable that the thickness of the EGL did
not significantly change. In contrast, in the control, the EGL
became substantially thicker. These data indicate that loss of
c- and N-myc almost completely impairs EGL thickening.
The myc DKO phenotypes in the cerebellum at E17.5
and P6 (Fig. 2a) were far more severe than that observed
with either single KO alone [16, 17]. These data indicate
that both c- and N-myc are essential for NSC function that
directs cerebellar genesis, or that N-myc is the central player
but its function can be compensated for by c-myc.
Interestingly, despite the apparent lethality of the nestin-cre
Myc DKO and the severe cerebellar phenotype, no elevation
of apoptosis was evident in the E17.5 in the cerebellum
(Electronic supplementary material, Fig. S1) or brain as a
whole (data shown). Therefore, c- and N-myc are not
essential for NSC survival.
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Fig. 1. Myc DKO results in lethality beginning as early as E17.5 and
impaired brain growth. a Ratios of the four genotypes of embryos or
pups of the indicated age produced from N-myc fl/fl; c-myc fl/fl mice
crossed with N-myc fl/wt; c-myc fl/fl nestin-cre+ mice. Note a genetic
linkage between the WT N-myc allele and nestin-cre transgene results
in an approximately 2-fold underrepresentation of N-myc fl/wt c-myc
fl/fl Cre− (control) and N-myc fl/fl c-myc fl/fl Cre+ (DKO) animals
independent of phenotype. DKOs are further underrepresented from
E17.5 onward indicating lethality. Numbers above bars are absolute
numbers of mice produced, italicized numbers above horizontal bars
are the expected number based on Mendelian ratios, and numbers
within bars are% of total pups/embryos. b Brain mass as a percentage
of WT. Asterisk Cre+
540 Cerebellum (2010) 9:537–547myc Family Expression Patterns in the Embryonic Brain
Correlate with the General Domain Specificity of myc
Knockout Phenotypes
We have previously observed high levels of N-Myc
protein expression in the develo p i n gc o r t e xa n dc e r e b e l l a
[16]. These findings correlated with myc family expression
data at E15.5 from the brain gene expression website:
http://www.stjudebgem.org/web/mainPage/mainPage.php.
While c-myc expression at the protein or RNA levels is
difficult to detect, there are hints of low-level expression
in a number of regions including the developing cortex. N-
myc is fairly ubiquitously expressed, but with relatively
lower or absent expression in some midbrain regions and
very high levels in the neocortex and the EGL. L-myc,
despite no reported KO phenotype, has very high
expression in the VZ of the embryonic midbrain, as well
as moderate levels in the developing cerebellum and
cortex.
A Lack of c- and N-myc Almost Completely Ablates
Cerebellar Development from P6-P21
To explore the effects of the myc DKO on cerebellar
development further, we examined the mature DKO
cerebellum. Between P6 and P21, the DKO cerebellum
grew little and there remained only one possible folium,
hardly recognizable as such. Reflective of little post-natal
cerebellar change in the DKO, a putative, residual EGL was
evident in the P21 DKO by DAPI staining (Fig. 3 blue
arrows). Staining of the DKO with NeuN, which highlights
cerebellar granule neurons, indicated an absence of the
internal granule cell layer (IGL) with a scattered pattern of
very few of granule neurons, abnormally intense NeuN
nuclear staining and possible reductions in nuclear size
(Fig. 3a). The astroglia and oligodendrocytes that normally
are present within the granule cell layer are ectopic and
disorganized in the DKO (Fig. 3a, b), with an overrepre-
sentation of astroglia and abnormal oligodendrocyte
P6 B
Control DKO
E17.5 A
Control DKO
Fig. 2. Myc cerebellar knock-
out phenotypes. a Sagittal
sections from control and DKO
embryonic cerebella (E17.5) or
b cerebella from pups (P6)
stained with Nissl. Scale
bars=100 μMi n( a) and in
(b) 500 μM
Cerebellum (2010) 9:537–547 541morphology. Purkinje neurons, which normally are present
at an enormous underrepresentation compared to granule
neurons, are also strikingly overrepresented in the DKO
(Fig. 3a versus b, BTUJ versus NeuN staining). This is
confirmed by Calbindin staining where a significant
fraction of total cells in the DKO cerebellum at P21 appear
to be Purkinje neurons (Fig. 4a).
Evidence of Arrested and Impaired Development
in the Mature DKO Cerebellum
While GAD67+ inhibitory neurons appear to be present in
the DKO, their location, staining, and morphology are all
very abnormal (Fig. 4a), suggesting a failure to mature
normally. Similarly, although c- and N-myc are not strictly
required for Purkinje neuron generation, nonetheless the
DKO Purkinje neurons exhibited evidence of impaired
maturity. The Purkinje neurons present are scattered and are
quite abnormal in morphology (Fig. 3, BTUJ and Fig. 4a,
Calbindin staining). While staining positive for both TUJ
and Calbindin, the staining of DKO Purkinje neurons is
abnormally intense. The Purkinje neurons appear to be
disconnected and do not form a visible neural network.
There is an absence of the normal beautiful arborization,
very evident in the control (Electronic supplementary
material, Fig. S2). It is unclear if these Myc-deficient
Purkinje neurons possess more than rudimentary axons and
dendrites, suggesting that although they are present their
DKO Control DKO
CNPase
TUJ
DAPI DAPI
Control
AB
Overlay Overlay
GFAP
NeuN
Fig. 3. Loss of c- and N-myc severely disrupts cerebellar develop-
ment. Control and DKO Sagittal cerebellar sections from mature
animals stained for DAPI (DNA; blue) or the indicated marker: a
NeuN (predominantly granule neurons) and GFAP (astroglia), b
CNPase (oligodendrocytes), and TUJ (BTUBIII; predominantly
Purkinje neurons). Blue arrows in (a, b) points toward DAPI stained
residual, abnormal EGL. Images were taken at 20× and scale bars=
100 μM. Note that the control images are from the tip of just one
folium, whereas the DKO images are nearly the entire cerebellum
542 Cerebellum (2010) 9:537–547development is impaired. The DKO cerebellum has a
severely attenuated, Math1+ EGL at E17 (Fig. 4b).
By P6, the DKO EGL is NeuN Positive and as Early
as E17.5 is Mostly Math1 Negative
To explore the events earlier in cerebellar development that
resulted in the severe DKO phenotype at maturity, we
examined the EGL at P6 (Fig. 4b). During this stage of
cerebellar development, the EGL normally consists of
Math1 positive, NeuN negative CGNPs. Normally, many
of the CGNPs have also begun to migrate inward to form a
Math1 negative, NeuN-positive developing IGL. The
findings from our staining for Math1 and NeuN in control
(doubly homozygously floxed, cre negative) sections were
consistent with this pattern (Fig. 5b; not shown). In striking
contrast, in the DKO we observed a phenotype where the
putative EGL has taken on an IGL-like fate, staining
negative for Math1 and positive for NeuN (arrows in
DKO panels in Fig. 5b; not shown). While the DKO has an
appropriately internally localized IGL consisting of strongly
NeuN-positive cells, it is highly disorganized and rostrally
no longer forms an actual layer. Furthermore, the DKO
cells located where the EGL should normally be are
moderately positive for NeuN as well. Therefore, Myc
deficiency alters CGNP fate, leading to a loss of CGNP
identity, likely explaining the residual EGL apparent at P21
in the DKO (Figs. 3 and 4a). To our knowledge this is the
first demonstration of an IGL-like phenotype in the EGL of
a KO mouse, suggesting Myc is essential for maintaining
CGNP identity and blocking differentiation. As early as
E17.5, the EGL in the DKO is nearly entirely lacking
Math1 positive cells, consistent with the notion of a loss
progenitor cell identity (Fig. 4c).
A
C
B
Control DKO
Math1
DAPI
DAPI
GAD67
Calbindin
DKO Control
Overlay
Adult
NeuN
DKO Control
P6
NeuN
E17.5
Fig. 4. Alterations in cell fate in the DKO. Control and DKO sagittal cerebellar sections stained for DAPI (DNA; blue) or the indicated marker: a
Adult. GAD67 (cytoplasm of inhibitory neurons) and Calbindin (Purkinje neurons, cytoplasm, and nucleus), b NeuN at P6, and c Math1 at E17.5
Cerebellum (2010) 9:537–547 543c- and N-Myc are essential for CGNP cell cycling and
metabolism To examine cell cycle characteristics of control
and Myc DKO cerebellar precursors, we stained E17
sections with anti-phosphoH3 antibody, a marker of
mitosis, as well as anti-BrdU antibody following BrdU
labeling (Fig. 5a). DKO cerebellar exhibited no clear
change in mitotic labeling cells in the rhombic lip, neuro-
epithelium and EGL. In contrast, all germinal regions of the
DKO showed a near complete absence of S phase cells as
determined by BrdU staining, while control neuroepithe-
lium, rhombic lip, and EGL exhibited a very high
proportion of S phase cells following a 2 h label, reflective
of the established very high proliferative rate in cerebellar
precursors at this stage. The absence of a clear change in M
phase cells together with a complete loss of S phase cells
suggests the few DKO cells that are cycling having
difficulty transiting M phase and there may be an M phase
block. To analyze the cell cycle further at P6, p27KIP1
staining was conducted (Fig. 5b). The control P6 cerebel-
lum has a handful of weakly p27-positive cells including a
few in the EGL, but none in the neuroepithelium. The DKO
cerebellum shows a striking induction of p27 throughout
both the EGL (white arrow) and the neuroepithelium
(yellow arrow). These data indicate that almost all DKO
CGNPs and NSC are strongly p27 positive, consistent with
the cell cycle exit suggested by the BrdU staining.
Myc has been previously linked to maintenance of cell
metabolism, leading us to examine whether the DKO affects
cerebellar precursor metabolism. To study potential metabolic
differences, we stained with antibody against the established
metabolic marker, nucleolin (Fig. 5c). The DKO cells in the
EGL and in the interior of the cerebellum exhibited a
pronounced decrease in nucleolin staining, reflecting im-
paired protein metabolism in the absence of c- and N-myc.
BrdU
pH3
DAPI
BrdU
DAPI
pH3
Control DKO
A
Control DKO
B
p27
Control DKO
Nucleolin
C
Fig. 5. Myc DKO decreases progenitor cell cycling at P6. a Control
and DKO E17.5 cerebella were stained with the indicated markers.
Green is phosphoH3; pH 3, a mitotic marker. Red is BrdU,
incorporated in S phase cells. Blue is DAPI. Images in a were taken
at 20× and scale bars=100 μM. b Staining for p27KIP1(green).
Yellow and white arrows indicate neuroepithelium and EGL, respec-
tively. Bars=200 μM. c Control and DKO E17.5 sagittal cerebellar
sections were stained with nucleolin (green), a marker of cell
metbolism. Images were taken at 40× and scale bars=100 μM
544 Cerebellum (2010) 9:537–547The decreased cellular metabolism in the DKO fits with the
disrupted cerebellar growth exhibited in the DKO.
Discussion
N-myc is required for normal murine and human brain
growth [16, 40]. Mutation of N-myc in humans causes FS
with its very large range of birth defects in a host of tissues
[41]. Interestingly the range of defects in constitutive N-
myc KO mice are remarkably similar to that of FS [42].
While these findings suggest a conserved role for N-myc in
both human and mouse NSC that drives brain growth, the
mechanisms have remained somewhat unclear. Complicat-
ing KO studies in mice has been the continued presence of
c-myc, which has increased expression in the N-myc KO
cerebellum and appears to compensate for the loss of N-
myc [36]. Our studies here using a DKO overcome this
problem, and point toward a key role for Myc in
maintaining essential cerebellar progenitor cell character-
istics: a specific cell cycle program, high metabolism,
and inhibited differentiation (i.e., maintained pluripo-
tency). In the Myc DKO mice, progenitors in the
cerebellum lose all these properties. The DKO behaves
akin to a developmental switch turning off, telling the
cerebellum, via its progenitor cells that its developmental
period is largely over as early as E17.5 and more
strongly by P6. Interestingly, at least at the developmen-
tal stages examined, there was no clear effect of the
DKO on survival.
One of the most striking features of the DKO is the
changes that occur in the EGL. At P6 the EGL normal
consists of CGNPs that are Math1+/NeuN−/BrdU+/p27−.
An IGL is already forming that consists of cells derived
from CGNPs that are almost the opposite, (e.g., Math1−/
NeuN+), that have migrated inward. In the DKO at P6, the
EGL has a phenotype very similar to that of the IGL,
consisting of cells that are Math1−/NeuN+/BrdU−/p27+.
However, like normal CGNPs of the EGL, these DKO cells
still reside in the EGL domain and form a multicell layer on
the outside of the developing cerebellum. They also consist
of cells with small, DAPI bright nuclei, a normal feature of
CGNPs in the EGL. Therefore, our data together suggest
that in the absence of c- and N-myc, the DKO CGNPs have
an aberrant cell fate. Instead of migrating inward, differen-
tiating, exiting the cell cycle, and remodeling their nucleus
into a larger, more euchromatic structure as normally
occurs, the DKO CGNPs mostly fail to migrate and
undergo an abnormal kind of differentiation right within
the EGL, where they also exit the cell cycle. The fact that
they nonetheless retain their location, layer structure,
nuclear morphology and DAPI staining suggests that at
one point they were CGNPs.
Other evidence of abnormal cell fate in the DKO comes
from the Purkinje neurons that are present in the mature
cerebellum. While they are overrepresented relative to
granule neurons, indicating that c- and N-myc are not
absolutely required for a Purkinje cell fate, the DKO
Purkinje neurons are abnormal in morphology. They lack
normal arborization and appear disconnected from the
cerebellar neural network. This may be a cell autonomous
phenotype due to loss of Myc in Purkinje progenitors, or
alternatively, maybe due to the absence of granule neurons/
migrating CGNPs that normal provide instructive signals
for Purkinje development. In the N-myc single nestin-cre-
driven KO cerebellum, Purkinje neurons are not overrepre-
sented and despite decreased granule neurons, the Purkinje
neurons still appear normal in morphology and connected-
ness. Therefore, the abnormal Purkinje maturation is unique
to the DKO.
The effects of loss of Myc on the cell cycle of cerebellar
progenitors are notable. While it is not surprising that the
loss of c- and N-myc leads to the near complete absence of
S phase cells, the presence of normal or near normal
numbers of M phase cells is unexpected. In the previous N-
myc single KOs driven by nestin-cre, decreases in both S
and M phase cell were observed. The fact that in the DKO,
there are almost no S phase cells but are relatively normal
numbers of M phase cells suggests the DKO progenitors
are blocked in M phase. This notion is supported by
expression microarray experiments in which a host of M
phase genes are downregulated in the DKO cerebellum
[43]. Since very few DKO progenitors were in S phase, it is
tempting to speculate that those few “cycling” cells are
mostly stuck in M phase, and that Myc is essential for
normal mitosis.
Further insight into Myc regulation of cerebellar devel-
opment would be gained by exploring the potential role of
the third main myc gene, L-myc, which is highly expressed
in the EGL. Although constitutive L-myc KO mice were
reported to have no phenotype of any kind, it seems
probable that the high L-myc levels in the EGL reflect a
f u n c t i o no b s c u r e di nt h eL - myc KO because of the
continued presence of very high levels of N-myc. Because
Purkinje neurons are overrepresented in the DKO, we
predict that L-myc plays a role in Purkinje neuron
development as well.
Conclusion
Overall our data indicate that N- and c-myc play particu-
larly important roles in cerebellar development. The
functions of c- and N-Myc proteins in the cerebellum
include maintaining pluripotency, metabolism, and cell
cycling of progenitors.
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